Clinical Utility of

PET/CT SUV adenocarcinoma esophageal cancer preoperative treatment staging

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
28 May 2023
Historique:
received: 08 04 2023
revised: 12 05 2023
accepted: 24 05 2023
medline: 10 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

Esophageal adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, is uncommon in the United States, but is associated with a rising incidence in young adults, and has a traditionally poor prognosis. Despite the incremental benefits that have been made with multimodality approaches to locally advanced disease, most patients will go on to develop metastatic disease, and long-term outcomes remain suboptimal. Over the last decade, PET-CT has emerged as a key tool in the management of this disease, with several prospective and retrospective studies evaluating its role in this disease. Herein, we review the key data pertaining to the use of PET-CT in the management of locally advanced esophageal and GEJ adenocarcinoma, with a focus on staging, prognostication, PET-CT adapted therapy in the neoadjuvant setting, and surveillance.

Identifiants

pubmed: 37296735
pii: diagnostics13111884
doi: 10.3390/diagnostics13111884
pmc: PMC10252409
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Am J Gastroenterol. 1999 Jan;94(1):20-9
pubmed: 9934727
Cancer. 1999 Mar 1;85(5):1026-32
pubmed: 10091784
Eur J Surg Oncol. 2003 Aug;29(6):506-10
pubmed: 12875856
J Thorac Cardiovasc Surg. 2007 Mar;133(3):738-45
pubmed: 17320575
Mol Imaging Biol. 2005 Nov-Dec;7(6):422-30
pubmed: 16270235
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
N Engl J Med. 2014 Dec 25;371(26):2499-509
pubmed: 25539106
J Clin Oncol. 2001 Jun 15;19(12):3058-65
pubmed: 11408502
BMC Med Imaging. 2020 Jan 22;20(1):7
pubmed: 31969127
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1191-202
pubmed: 21365252
Lancet Oncol. 2007 Sep;8(9):797-805
pubmed: 17693134
J Nucl Med. 1998 Jun;39(6):1002-7
pubmed: 9627333
J Clin Oncol. 2004 Sep 15;22(18):3805-12
pubmed: 15365078
J Am Coll Surg. 2010 Apr;210(4):428-35
pubmed: 20347734
Am Surg. 2000 Sep;66(9):827-31
pubmed: 10993609
Ann Oncol. 2020 Feb;31(2):236-245
pubmed: 31959340
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Nucl Med. 2015 Jul;56(7):995-1002
pubmed: 25952733
Cureus. 2018 Dec 10;10(12):e3709
pubmed: 30788198
Gastroenterology. 2018 Jan;154(2):360-373
pubmed: 28823862
N Engl J Med. 1998 Dec 31;339(27):1979-84
pubmed: 9869669
Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60
pubmed: 15464463
Dis Esophagus. 2022 Dec 14;35(12):
pubmed: 35788834
Cancer. 2012 Jun 1;118(11):2820-7
pubmed: 21990000
Ann Surg. 2020 Feb;271(2):245-256
pubmed: 31188203
J Nucl Med. 2015 Aug;56(8):1150-6
pubmed: 26089549
Target Oncol. 2018 Feb;13(1):99-106
pubmed: 29218623
Clin Nucl Med. 2018 Dec;43(12):887-894
pubmed: 30300200
Gastrointest Endosc. 2009 Jun;69(7):1210-7
pubmed: 19012886
Dis Esophagus. 2009;22(8):668-75
pubmed: 19222534
J Thorac Oncol. 2013 Dec;8(12):1563-9
pubmed: 24389439
Cancer. 2003 Apr 1;97(7):1616-23
pubmed: 12655517
Cancer. 2004 Oct 15;101(8):1776-85
pubmed: 15386332
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1008-15
pubmed: 19352191
Radiother Oncol. 2008 Dec;89(3):278-86
pubmed: 18701180
Nucl Med Mol Imaging. 2018 Feb;52(1):5-15
pubmed: 29391907
J Clin Oncol. 2006 Sep 10;24(26):4347-55
pubmed: 16963732
J Clin Oncol. 2021 Sep 1;39(25):2803-2815
pubmed: 34077237
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1595-606
pubmed: 21559979
N Engl J Med. 2021 Apr 1;384(13):1191-1203
pubmed: 33789008
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Thorac Surg Clin. 2022 Nov;32(4):437-445
pubmed: 36266031
J Nucl Med. 2011 Aug;52(8):1189-96
pubmed: 21764790
Br J Cancer. 2008 Feb 12;98(3):547-57
pubmed: 18212745
J Clin Oncol. 2006 Oct 10;24(29):4692-8
pubmed: 16966684
Dis Esophagus. 2017 Feb 1;30(3):1-8
pubmed: 27862622
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200
pubmed: 19915839
Cancer. 2016 Jul 1;122(13):2083-90
pubmed: 27152857
Ann Surg. 2023 Mar 1;277(3):e538-e544
pubmed: 34387205
Lancet. 2019 May 11;393(10184):1948-1957
pubmed: 30982686
N Engl J Med. 2012 May 31;366(22):2074-84
pubmed: 22646630
Ann Surg. 2022 Dec 1;276(6):1017-1022
pubmed: 33214465
J Thorac Cardiovasc Surg. 2003 May;125(5):1103-13
pubmed: 12771884
Cancer. 2002 Oct 1;95(7):1434-43
pubmed: 12237911
J Thorac Oncol. 2013 Dec;8(12):1558-62
pubmed: 24389438
Nucl Med Commun. 2021 Apr 1;42(4):437-443
pubmed: 33306638

Auteurs

Darren Cowzer (D)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Fergus Keane (F)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Geoffrey Y Ku (GY)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Department of Medicine, Weill Cornell University, New York, NY 10065, USA.

Classifications MeSH